Dermata Therapeutics (DRMA) Debt Ratio (2020)
Dermata Therapeutics (DRMA) posted quarterly Debt Ratio of 0.92 for Q4 2020.
Dermata Therapeutics (DRMA) Debt Ratio (2020) Analysis & Trends
Dermata Therapeutics' Debt Ratio history runs 1 years deep, the most recent figure standing at 0.92 for Q4 2020.
- In Q4 2020, Debt Ratio changed N/A year-over-year to 0.92; the TTM figure through Dec 2020 stood at 0.92 (changed N/A YoY), while the FY2020 annual figure was 0.92, changed N/A from the prior year.
- Debt Ratio for Q4 2020 stood at 0.92.
- The five-year high for Debt Ratio was 0.92 in Q4 2020, with the low at 0.92 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.47 |
| 10 | Dermata Therapeutics | 5.40 Mn | 5.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 0.92 |